A stacking ensemble machine learning model to predict alpha-1 antitrypsin deficiency-associated liver disease clinical outcomes based on UK Biobank data | Scientific Reports
Alpha-1 antitrypsin deficiency - Wikipedia
State of the Evidence for AAT Therapy in AATD | Journal of The COPD Foundation
α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action - The Lancet Respiratory Medicine
What Is the Life Expectancy of Someone With Alpha-1 Antitrypsin Deficiency?
The effect of α1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study - ScienceDirect
Treatment - Alpha-1 Foundation
Global Alpha-1 Antitrypsin Drugs Market 2018-2022| Rising Patient Assistance Programs to Spur Growth| Technavio | BioSpace
Living with Alpha-1 Antitrypsin Deficiency: Empowering Patients and Healthcare Professionals - European Medical Journal
Impact of COVID-19 infection in patients with alpha-1 antitrypsin deficiency
α1-Antitrypsin deficiency • 3: Clinical manifestations and natural history | Thorax
Suspecting and Testing for Alpha-1 Antitrypsin Deficiency—An Allergist's and/or Immunologist's Perspective - ScienceDirect
Alpha1-Antitrypsin Deficiency | NEJM
Surgery for patients with Alpha 1 Antitrypsin Deficiency: A review - ScienceDirect
The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database | European Respiratory Society
Alpha1-Antitrypsin Deficiency | NEJM
Alpha-1-antitrypsin deficiency symptoms | Asthma + Lung UK
The prevalence of diagnosed α1-antitrypsin deficiency and its comorbidities: results from a large population-based database | European Respiratory Society
Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Defi | TCRM
Alpha-1 UK Support Group | Facebook
Testing for α 1 -antitrypsin deficiency (AATD) and the estimated number... | Download Table